Compound Calcium Gluconate Oral Solution Analysis Service
Client Satisfaction Is Our Objective for the Compound Calcium Gluconate Oral Solution Analysis
CD BioGlyco provides high-quality analysis services for a wide range of Pharmaceuticals, including Voglibose, Heparin Calcium, Heparin Sodium, compound calcium gluconate oral solution, etc. Compound calcium gluconate oral solution is a calcium supplement that contains calcium lactate with calcium gluconate. It promotes the calcification of bones and teeth and maintains and reduces the permeability of capillaries which is often used in the prevention of calcium deficiency. We provide a high-quality compound calcium gluconate oral solution analysis service to support our clients' research on its functionality, pharmacodynamics, and more. We have an experienced team in Pharmaceutical and Biological Analysis to make the project fast and efficient. Compound calcium gluconate oral solution is analyzed for the following items:
- Routine tests: Trait observation, pH
- Pharmaceutical identification test: The samples are identified by thin-layer chromatography (TLC).
- Microbiological test: We have a range of microbiological testing methods.
- Relative density: The relative density test is used to check the degree of purity and impurity of the pharmaceutical.
- Determination of content: The amount of Ca and others in the samples are detected.
- Purity analysis: The amount and type of impurities contained in the sample will be detected.
- Pharmaceutical safety evaluation: Endotoxin, bioburden, etc.
We possess various advanced methodologies and techniques for pharmaceutical analysis. In addition to the above assays, we also complete other compound calcium gluconate oral solution-related analyses. Our optimized analytics solutions allow us to produce results quickly and shorten project delivery times.
Fig.1 Compound calcium gluconate oral solution analysis service. (CD BioGlyco)
Publication Data
Journal: Basic & Clinical Pharmacology & Toxicology
IF: 3.267
Published: 2011
Results: This study examined the effect of calcium gluconate on ligation-induced experimental periodontitis and associated alveolar bone loss. The results showed that calcium gluconate treatment exerted beneficial effects on an animal model of alveolar bone loss and periodontitis.
Fig.2 Chemical structure of calcium gluconate used in this study. (Ku, et al., 2011)
Frequently Asked Questions
- What is the function of compound calcium gluconate oral solution?
It has the functions of maintaining normal excitability of nerves and muscles, promoting calcification of bones and teeth, reducing capillary permeability, etc. It is currently used in osteoporosis and rickets.
- What are the basic steps in TLC for the identification of compound calcium gluconate oral solution?
- The sample to be tested is spotted on a thin layer plate.
- The 8-hydroxyquinoline solution is sprayed onto the sample and allowed to dry.
- Then we spray the ammonia test solution and heat.
- This is followed by the color development of the thin layer plates with a UV lamp.
- We observe the spots on the thin layer plate and compare them with the control to determine the identity of the sample to be tested.
Advantages of Us
- Our analytical methods are diversified, sample processing is simple, and the analytical results are accurate.
- We have a perfect pharmaceutical analysis project management system to ensure that the compound calcium gluconate oral solution analysis projects are delivered with high quality and efficiency.
- Our compound calcium gluconate oral solution analytical projects are very complete, including microbiological testing, drug identification, content determination, etc.
At CD BioGlyco, we develop detailed and appropriate analytical protocols for each drug product. Please feel free to contact us to learn more about analyzing compound calcium gluconate oral solution. Our analytical team will get back to you as soon as possible with answers to all your questions.
Reference
-
Ku, S.K.; et al. Effects of calcium gluconate on experimental periodontitis and alveolar bone loss in rats. Basic & Clinical Pharmacology & Toxicology. 2011, 108(4): 241-250.
This service is for Research Use Only, not intended for any clinical use.